54325 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Jul 21
13:36 UTC
|
CLX
Clorox
|
◎ Target | Lauren Lieberman ★★☆☆☆ #2369 | Underweight | $85.00→ $86.00+1.2% |
|
Jul 21
13:36 UTC
|
CL
Colgate-Palmolive
|
◎ Target | Lauren Lieberman ★★☆☆☆ #2369 | Equal Weight | $80.00→ $87.00+8.8% |
|
Jul 21
13:36 UTC
|
CHD
Church & Dwight
|
◎ Target | Lauren Lieberman ★★☆☆☆ #2369 | Underweight | $79.00→ $86.00+8.9% |
|
Jul 21
13:36 UTC
|
CCK
Crown
|
◎ Target | John Roberts not yet tracked | Outperform | $130.00→ $135.00+3.8% |
|
Jul 21
13:36 UTC
|
CCEP
Coca-Cola Europacific Partners
|
◎ Target | Lauren Lieberman ★★☆☆☆ #2369 | Overweight | $108.00→ $114.00+5.6% |
|
Jul 21
13:36 UTC
|
BXP
BXP
|
◎ Target | Vikram Malhotra ★★★☆☆ #1046 | Neutral | $62.00→ $68.00+9.7% |
|
Jul 21
13:36 UTC
|
BXP
BXP
|
◎ Target | Brendan Lynch ★★★☆☆ #1838 | Overweight | $65.00→ $79.00+21.5% |
|
Jul 21
13:36 UTC
|
BRBR
BellRing Brands
|
◎ Target | Andrew Lazar ★★★☆☆ #2120 | Overweight | $13.00→ $14.00+7.7% |
|
Jul 21
13:36 UTC
|
BIIB
Biogen
|
◎ Target | Jason Zemansky ★★☆☆☆ #2681 | Neutral | $217.00→ $215.00-0.9% |
|
Jul 21
13:36 UTC
|
BGS
B&G Foods
|
◎ Target | Brandt Montour ★★★☆☆ #2167 | Equal Weight | $6.00→ $5.00-16.7% |
|
Jul 21
13:36 UTC
|
AIT
Applied Industrial Technologies
|
◎ Target | Brett Linzey ★★★☆☆ #1284 | Outperform | $330.00→ $355.00+7.6% |
|
Jul 21
13:36 UTC
|
AIRO
AIRO Group
|
◎ Target | Brett Linzey ★★★☆☆ #1284 | Outperform | $16.00→ $13.00-18.8% |
|
Jul 21
13:36 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Evan David Seigerman not yet tracked | Outperform | $34.00→ $36.00+5.9% |
|
Jul 21
13:36 UTC
|
ZION
Zions Bancorporation, N.A.
|
↓ Downgrade | Anthony Elian ★★☆☆☆ #2651 | Neutral→ Underweight | $75.00 |
|
Jul 21
13:36 UTC
|
WDAY
Workday
|
↓ Downgrade | Keith Weiss ★★★★★ #320 | Equal Weight→ Underweight | $185.00→ $145.00-21.6% |
|
Jul 21
13:36 UTC
|
LYV
Live Nation Entertainment
|
↓ Downgrade | firm only | Positive→ Neutral | $186.00 |
|
Jul 21
13:36 UTC
|
HZO
MarineMax
|
↓ Downgrade | firm only | Buy→ Neutral | $35.00 |
|
Jul 21
13:36 UTC
|
GILD
Gilead Sciences
|
↓ Downgrade | firm only | Outperform→ Market Perform | $127.00 |
|
Jul 21
13:36 UTC
|
CINT
CI&T
|
↓ Downgrade | Steven Wahrhaftig ★★☆☆☆ #2833 | Outperform→ Neutral | |
|
Jul 21
13:36 UTC
|
VLX
Volex
|
↑ Upgrade | firm only | Buy | GBX 590→ GBX 600+1.7% |
|
Jul 21
13:36 UTC
|
KMX
CarMax
|
↑ Upgrade | John Babcock ★★☆☆☆ #2790 | Underweight→ Equal Weight | $61.00 |
|
Jul 21
13:36 UTC
|
HLT
Hilton Worldwide
|
↑ Upgrade | firm only | In-Line→ Outperform | |
|
Jul 21
13:36 UTC
|
DTRUY
Daimler Truck
|
↑ Upgrade | firm only | Reduce→ Buy | |
|
Jul 21
13:36 UTC
|
AHCO
AdaptHealth
|
↑ Upgrade | Brian Tanquilut ★★★★☆ #646 | Hold→ Buy | $11.00→ $13.00+18.2% |
|
Jul 21
12:36 UTC
|
ZION
Zions Bancorporation, N.A.
|
◎ Target | David George ★★★★☆ #558 | Neutral | $68.00→ $75.00+10.3% |
|
Jul 21
12:36 UTC
|
WEX
WEX
|
◎ Target | Michael Infante ★★★☆☆ #1998 | Equal Weight | $161.00→ $172.00+6.8% |
|
Jul 21
12:36 UTC
|
TDOC
Teladoc Health
|
◎ Target | Richard Close ★★★☆☆ #1610 | Buy | $10.00→ $11.00+10.0% |
|
Jul 21
12:36 UTC
|
SPGI
S&P Global
|
◎ Target | Jeffrey Meuler ★★★☆☆ #1059 | Outperform | $520.00→ $521.00+0.2% |
|
Jul 21
12:36 UTC
|
PGNY
Progyny
|
◎ Target | Richard Close ★★★☆☆ #1610 | Buy | $30.00→ $36.00+20.0% |
|
Jul 21
12:36 UTC
|
OMDA
Omada Health
|
◎ Target | Richard Close ★★★☆☆ #1610 | Buy | $24.00→ $28.00+16.7% |
|
Jul 21
12:36 UTC
|
META
Meta Platforms
|
◎ Target | Dominic Ball ★★☆☆☆ #2692 | Buy | $900.00→ $1,000.00+11.1% |
|
Jul 21
12:36 UTC
|
LFST
LifeStance Health Group
|
◎ Target | Richard Close ★★★☆☆ #1610 | Buy | $11.00→ $13.00+18.2% |
|
Jul 21
12:36 UTC
|
HSTM
HealthStream
|
◎ Target | Richard Close ★★★☆☆ #1610 | Hold | $24.00→ $27.00+12.5% |
|
Jul 21
12:36 UTC
|
HOOD
Robinhood Markets
|
◎ Target | John Todaro ★★☆☆☆ #2292 | Buy | $97.00→ $123.00+26.8% |
|
Jul 21
12:36 UTC
|
HNGE
Hinge Health
|
◎ Target | Richard Close ★★★☆☆ #1610 | Buy | $76.00→ $100.00+31.6% |
|
Jul 21
12:36 UTC
|
HCAT
Health Catalyst
|
◎ Target | Richard Close ★★★☆☆ #1610 | Buy | $2.00→ $3.00+50.0% |
|
Jul 21
12:36 UTC
|
EVH
Evolent Health
|
◎ Target | Richard Close ★★★☆☆ #1610 | Buy | $6.00→ $7.00+16.7% |
|
Jul 21
12:36 UTC
|
DT
Dynatrace
|
◎ Target | Brent Thill ★★★☆☆ #2100 | Buy | $45.00→ $55.00+22.2% |
|
Jul 21
12:36 UTC
|
DPZ
Domino's Pizza
|
◎ Target | firm only | Outperform | $465.00→ $415.00-10.8% |
|
Jul 21
12:36 UTC
|
CTEV
Claritev
|
◎ Target | Richard Close ★★★☆☆ #1610 | Buy | $32.00→ $37.00+15.6% |
|
Jul 21
12:36 UTC
|
CLOV
Clover Health Investments
|
◎ Target | Richard Close ★★★☆☆ #1610 | Buy | $4.20→ $5.50+31.0% |
|
Jul 21
12:36 UTC
|
CALX
Calix
|
◎ Target | Mike Genovese not yet tracked | Buy | $70.00→ $55.00-21.4% |
|
Jul 21
12:36 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Paul Matteis ★★★☆☆ #1392 | Hold | $24.00→ $25.00+4.2% |
|
Jul 21
12:36 UTC
|
WIX
Wix.com
|
↓ Downgrade | Elizabeth Porter ★★★☆☆ #1012 | Overweight→ Equal Weight | $112.00→ $60.00-46.4% |
|
Jul 21
12:36 UTC
|
WDAY
Workday
|
↓ Downgrade | Keith Weiss ★★★★★ #320 | Overweight→ Underweight | $185.00→ $145.00-21.6% |
|
Jul 21
12:36 UTC
|
TRV
Travelers Companies
|
↓ Downgrade | Michael Zaremski ★★★★☆ #527 | Outperform→ Market Perform | $314.00→ $379.00+20.7% |
|
Jul 21
12:36 UTC
|
TRIP
TripAdvisor
|
↓ Downgrade | Jake Fuller ★★★☆☆ #2018 | Buy→ Neutral | |
|
Jul 21
12:36 UTC
|
SPSC
SPS Commerce
|
↓ Downgrade | Chris Quintero ★★★☆☆ #1911 | Overweight→ Underweight | $70.00→ $57.00-18.6% |
|
Jul 21
12:36 UTC
|
RPD
Rapid7
|
↓ Downgrade | Meta Marshall ★★★☆☆ #1577 | Equal Weight→ Underweight | $9.00 |
|
Jul 21
12:36 UTC
|
PD
PagerDuty
|
↓ Downgrade | Sanjit Singh ★★☆☆☆ #2408 | Equal Weight→ Underweight | $10.00→ $9.00-10.0% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.